Scientists track immune cells to improve lung cancer care
Knowledge-focused
Ongoing
This study aims to understand how the immune system changes in stage III non-small cell lung cancer patients receiving standard treatment. Researchers will observe 45 patients undergoing chemoradiation followed by immunotherapy (durvalumab) to identify immune markers that might p…
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC